Individuals with low-risk monoclonal gammopathy have a reduced risk of developing cancerous conditions. More specifically, they have a two percent chance of their condition progressing to multiple myeloma or a related disorder within the next 20 years. These individuals tend to have an IgG type M-protein in the blood, an M-protein level of less than 15g/L, and a normal free light chain ratio.

Hailshadow / Getty Images
This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.